CClinicalTrials.gg
Status unknownNCT03903497Updated May 18, 2022

WASP Classification in Diagnosis of Diminutive Colorectal Polyps

An interventional study of NBI in Diminutive Colorectal Polyps, sponsored by Shanghai Jiao Tong University School of Medicine. Status unknown at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-18.

Sponsored by Shanghai Jiao Tong University School of Medicine · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
2,640
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Adenomas, serrated adenomas and hyperplastic polyps are polypoid lesion in the colorectum. At the present moment, all polyps should be resected endoscopically, although only adenomas and serrated adenomas, but not hyperplastic polyps have the potential to develop colorectal cancer. Some studies have investigated the value of the narrow-band imaging (NBI) on histological prediction of the polyp. This method is conducted in real time during colonoscopy, which leads to simplification of diagnostic procedures. For instance, it would be conceivable to resect diminutive polyps and discard them without further assessment by a pathologist. One problem in this context is a correct differentiation between hyperplastic polyps and serrated adenomas. These two polyp entities are known to show similar optical features. However, while serrated adenomas are premalignant lesions hyperplastic polyps have benign histology and never develop into cancer. It is therefore important to sufficiently distinguish hyperplastic polyps from serrated lesions.

In this study the investigators want to investigate whether the use of NBI would be capable to get accuracy of optical polyp predictions by more than 90% using the WASP (Workgroup serrAted polypS and Polyposis) classification. NBI is a light filter tool which can be activated by pressing a button at the endoscope. The use of NBI leads to an endoscopic picture which appears blue and enables endoscopists to better assess surface structures and vascular patterns. All polyps will be resected and send to pathology for further microscopic assessment. After completing the trial the investigators aim to compare accuracy of the optical diagnosis.

02

Conditions studied

  • Diminutive Colorectal Polyps

Browse trials for

Keywords

  • Narrow band imaging
  • WASP classification
  • Diminutive colorectal polyps
03

In context

Polyps

385 studies on the registry are indexed under Polyps; 59 are open to participants now.

This study's planned enrollment of 2,640 is above the median of 160 across 250 interventional studies indexed under Polyps.

Browse Polyps studies →

Lead sponsor

Shanghai Jiao Tong University School of Medicine is the lead sponsor of 358 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged more than 18 years old
  • Patients with at least one diminutive colorectal polyp

Exclusion criteria

Exclusion Criteria:

  • Patients with poor bowel preparation
  • Paitents with history of colorectal surgery, familial adenomatous polyposis or inflammatory bowel disease
  • Patients with advanced colorectal cancer
  • Patients with missed histology information of resected polyps or missed resected specimen
  • Patients with emergency operation during colonoscopy
  • Patients with unfinished colonoscopy due to any reason
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
2,640 participants (estimated)

Study arms

  • Other
    NBI assessment using the WASP classification

    Device: NBI

Interventions

  • DeviceNBI

    optical assessment of diminutive colorectal polyps by NBI mode using the WASP assessment

06

What researchers measure

Primary outcomes

  1. Accuracy of Surveillance time prediction of patients with at least one diminutive polyps under high confidence of diagnosis

    Time frame: Within two weeks after polypectomy

  2. Negative predictive value of diminutive polyps located in rectum and sigmoid colon under high confidence of diagnosis

    Time frame: Within two weeks after polypectomy

  3. Accuracy of WASP classification in histological prediction of diminutive polyps under high confidence of diagnosis

    Time frame: Within two weeks after polypectomy

Secondary outcomes

  1. Learning curve of accuracy of endoscopists using NBI in assessment of diminutive polyps

    Time frame: Within two weeks after polypectomy

07

Study locations

2 of 2 sites recruiting
  • Beijing Friendship Hospital
    Beijing, Beijing 100050, China
    • Shu-Tian Zhang · Contact
    • Shu-Tian Zhang, MD · Principal investigator
    Recruiting
  • Renji Hospital
    Shanghai, Shanghai 200001, China
    • Zhi-Zheng Ge · Contact · zhizhengge@aliyun.com · 021-58752345
    • Zhi-Zheng Ge, MD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03903497
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Collaborators
Beijing Friendship Hospital, Jilin People's Hospital, Wafangdian Third Hospital, Dezhou People's Hospital, Liaocheng People's Hospital, Wenzhou Central Hospital, Yichun People's Hospital, The Third Xiangya Hospital of Central South University, Shenzhen Baoan People's Hospital, Xinxiang Central Hospital, Wuwei Cancer Hospital, Zunyi Medical College, Yaan People's Hospital
Responsible party
Zhizheng Ge (MD,Ph.D, Shanghai Jiao Tong University School of Medicine) — Principal investigator
First posted
Apr 4, 2019
Start date
Apr 15, 2019
Primary completion
Dec 30, 2022 (estimated)
Completion
May 30, 2023 (estimated)
Last update
May 18, 2022

Study contacts

Zhi-Zheng Ge
Contact
zhizhengge@aliyun.com
021-58752345

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion